The E3-ubiquitin ligase c-Cbl regulates protease-activated receptor 2 (PAR2)

被引:0
|
作者
Jacob, C
Cottrell, G
Schmidlin, F
Grady, EF
Bunnett, NW
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A413 / A413
页数:1
相关论文
共 50 条
  • [21] Mast cells signal to colonocytes by release of tryptase and activation of protease-activated receptor 2 (par2)
    Saito, T
    Amadesi, S
    Cottrell, GS
    Grady, EF
    Bunnett, NW
    GASTROENTEROLOGY, 2005, 128 (04) : A192 - A192
  • [22] Mast cells induce epithelial barrier dysfunction by activation of protease-activated receptor 2 (PAR2)
    Grady, EF
    Yang, PC
    Amadesi, S
    Jacob, C
    Cottrell, GS
    Singh, P
    Darmoul, D
    Perdue, M
    Bunnett, NW
    GASTROENTEROLOGY, 2004, 126 (04) : A519 - A519
  • [23] PROTEASE-ACTIVATED RECEPTOR (PAR)2 REGULATES B-LYMPHOCYTE FUNCTION
    McKelvey, K.
    Xue, M.
    Jackson, C.
    WOUND REPAIR AND REGENERATION, 2012, 20 (05) : A74 - A74
  • [24] The E3 ligase c-Cbl regulates dendritic cell activation
    Chiou, Shin-Heng
    Shahi, Payam
    Wagner, Ryan T.
    Hu, Hongbo
    Lapteva, Natalia
    Seethammagari, Mamatha
    Sun, Shao-Cong
    Levitt, Jonathan M.
    Spencer, David M.
    EMBO REPORTS, 2011, 12 (09) : 971 - 979
  • [25] Protease-activated receptor(PAR)1, PAR2 and PAR4 expressions in esophageal squamous cell carcinoma
    Si-Man LI
    Ping JIANG
    Yang XIANG
    Wei-Wei WANG
    Yue-Chun ZHU
    Wei-Yang FENG
    Shu-De LI
    Guo-Yu YU
    Zoological Research, 2014, 35 (05) : 420 - 425
  • [26] Expression and functional characterization of protease-activated receptor 2 (PAR2) and PAR1 on human skin mast cells
    Fukuoka, Yoshihiro
    Sanchez-Munoz, Laura B.
    Dellinger, Anthony L.
    Schwartz, Lawrence B.
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [27] Protease Activated Receptor 2 (PAR2): A Novel Regulator of Osteoclastogenesis
    Mcgrath, Sarah
    Hultin, Leif
    Lockhart, John C.
    Goodyear, Carl S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 379 - 380
  • [28] Pepducin - A Novel Protease-Activated Receptor-2 (par2) Inhibitor - Attenuates Experimental Pulmonary Hypertension
    Warburton, R.
    Kuliopulos, A.
    Wieschhaus, A.
    Kayyali, U. S.
    Toksoz, D.
    Fanburg, B. L.
    Preston, I. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [29] Protease-activated receptor 2 (PAR2)-targeting peptide derivatives for positron emission tomography (PET) imaging
    LeSarge, Jordan C.
    Thibeault, Pierre
    Yu, Lihai
    Childs, Marina D.
    Mirka, Victor M.
    Qi, Qi
    Fox, Matthew S.
    Kovacs, Michael S.
    Ramachandran, Rithwik
    Luyt, Leonard G.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 246
  • [30] Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2
    Kanke, T
    Ishiwata, H
    Kabeya, M
    Saka, M
    Doi, T
    Hattori, Y
    Kawabata, A
    Plevin, R
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (02) : 255 - 263